Amphix Bio
Amphix Bio is a preclinical stage company developing a new platform technology, Supramolecular Therapeutic Peptides (STPs), that modifies immunological response and initiates regenerative processes to restore function lost from injury, disease, or aging. These therapies trigger targeted signaling pathways while forming scaffolds to support biological repair. Amphix Bio's goal is to increase human healthspan — the length of time that people can live productive, fulfilling lives.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Amphix Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- NS
Nick Sather
Associate Director for Translational Research & Technology Transfer · Other
EmailPhone - CC
Charlotte Chen
Lead R & d Scientist · Science
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Amphix Bio
3 distinct titles indexed · top 3 shown.
- 1alector
- 1associate director for translational research & technology transfer
- 1lead r & d scientist
Sign up to unlock all 3 contacts at Amphix Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Amphix Bio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.